<DOC>
	<DOCNO>NCT00461617</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Mitiglinide compare Nateglinide treatment type 2 diabetes .</brief_summary>
	<brief_title>Double-Blind Comparison Between Mitiglinide Nateglinide Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Nateglinide</mesh_term>
	<mesh_term>Mitiglinide</mesh_term>
	<criteria>Type 2 diabetes patient inadequate control blood glucose diet and/or exercise therapy Type 1 diabetes patient Patients require treatment insulin Patients severe diabetic complication ( neuropathy , retinopathy nephropathy ) Patients severe ketosis , diabetic coma precoma Patients complicate severe hepatic disease Patients complicate severe renal disease Patients complicate severe hypertension Patients complicate severe cardiac disease Pregnant woman woman possible pregnant , nursing woman , woman want become pregnant study period</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>diabetes</keyword>
	<keyword>rapid short act insulin secretagogue</keyword>
	<keyword>Î±-glucosidase inhibitor</keyword>
	<keyword>HbA1C</keyword>
	<keyword>insulin</keyword>
</DOC>